394 Sentinel lymph node mapping vs systematic lymphadenectomy for endometrial cancer: surgical morbidity and lymphatic complications. (18th September 2019)
- Record Type:
- Journal Article
- Title:
- 394 Sentinel lymph node mapping vs systematic lymphadenectomy for endometrial cancer: surgical morbidity and lymphatic complications. (18th September 2019)
- Main Title:
- 394 Sentinel lymph node mapping vs systematic lymphadenectomy for endometrial cancer: surgical morbidity and lymphatic complications
- Authors:
- Accorsi, G
dos Reis, R
Schmidt, R
Lacerda, L
Vieira, M
Andrade, C - Abstract:
- Abstract : Objectives: Sentinel lymph node (SLN) mappinghas been proven to accurately stage endometrial cancer (EC). However, there is a lack of studies comparing the incidence of complications between different lymph node approaches in EC. Our objective is to define the complication rates of SLN biopsy in EC patients. Methods: We retrospectively analyzed all patients with EC surgically treated at Barretos Cancer Hospital between April 2013 and March 2018. We evaluated intraoperative complications and 30-day complications using the Memorial Sloan Lettering Cancer Center's Surgical Secondary Events Grading System, separating the patients into four groups: hysterectomy (HT); hysterectomy plus pelvic lymphadenectomy, with or without para-aortic dissection (HT+LND); hysterectomy plus sentinel biopsy (HT+SLN); and hysterectomy plus lymphadenectomy and sentinel biopsy (HT+SLN+LND). Results: As compared with the HT group, the HT+SLN group did not show any increased risk of complications in terms of intraoperative injury (0vs1; p =1.0) and 30-day complications (8vs7; p =0.782).The HT+LND group had an increased surgical time (370 min, p <0.001), greater intraoperative blood loss (100cc, p <0.001), and a higher incidence of injury during surgery (7%, p =0.005) and any 30-day complication (38.2%, p =0.002) as compared with HT+SLN. Performing LND was associated with a greater risk of 30-day complications (hazard ratio [HR]:14.25; 95% confidence interval [CI]:1.85–19.63) andAbstract : Objectives: Sentinel lymph node (SLN) mappinghas been proven to accurately stage endometrial cancer (EC). However, there is a lack of studies comparing the incidence of complications between different lymph node approaches in EC. Our objective is to define the complication rates of SLN biopsy in EC patients. Methods: We retrospectively analyzed all patients with EC surgically treated at Barretos Cancer Hospital between April 2013 and March 2018. We evaluated intraoperative complications and 30-day complications using the Memorial Sloan Lettering Cancer Center's Surgical Secondary Events Grading System, separating the patients into four groups: hysterectomy (HT); hysterectomy plus pelvic lymphadenectomy, with or without para-aortic dissection (HT+LND); hysterectomy plus sentinel biopsy (HT+SLN); and hysterectomy plus lymphadenectomy and sentinel biopsy (HT+SLN+LND). Results: As compared with the HT group, the HT+SLN group did not show any increased risk of complications in terms of intraoperative injury (0vs1; p =1.0) and 30-day complications (8vs7; p =0.782).The HT+LND group had an increased surgical time (370 min, p <0.001), greater intraoperative blood loss (100cc, p <0.001), and a higher incidence of injury during surgery (7%, p =0.005) and any 30-day complication (38.2%, p =0.002) as compared with HT+SLN. Performing LND was associated with a greater risk of 30-day complications (hazard ratio [HR]:14.25; 95% confidence interval [CI]:1.85–19.63) and intraoperative injury (HR:3.11; 95% CI:1.62–5.98). Conclusions: SLN mapping does not increase morbidity in the surgical treatment of EC patients, and compared with comprehensive lymphadenectomy, it has a lower risk of complications. Our findings support the use of the SLN algorithm in EC patients. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 29(2019)Supplement 3
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 29(2019)Supplement 3
- Issue Display:
- Volume 29, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 3
- Issue Sort Value:
- 2019-0029-0003-0000
- Page Start:
- A162
- Page End:
- A164
- Publication Date:
- 2019-09-18
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2019-IGCS.394 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19725.xml